CHROMOGRANIN-A IMMUNOREACTIVITY IN HUMAN CEREBROSPINAL-FLUID - PROPERTIES, RELATIONSHIP TO NORADRENERGIC NEURONAL-ACTIVITY, AND VARIATION IN NEUROLOGIC DISEASE

Citation
Dt. Oconnor et al., CHROMOGRANIN-A IMMUNOREACTIVITY IN HUMAN CEREBROSPINAL-FLUID - PROPERTIES, RELATIONSHIP TO NORADRENERGIC NEURONAL-ACTIVITY, AND VARIATION IN NEUROLOGIC DISEASE, Neuroscience, 56(4), 1993, pp. 999-1007
Citations number
47
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
03064522
Volume
56
Issue
4
Year of publication
1993
Pages
999 - 1007
Database
ISI
SICI code
0306-4522(1993)56:4<999:CIIHC->2.0.ZU;2-C
Abstract
Although measurement of chromogranin A in the bloodstream is of value in sympathoadrenal investigations, little is systematically known abou t chromogranin A in cerebrospinal fluid, despite substantial knowledge about its occurrence and distribution in brain. We therefore applied a homologous human chromogranin A radioimmunoassay to cerebrospinal fl uid, in order to evaluate the properties and stability of cerebrospina l fluid chomogranin A, as well as its relationship to central noradren ergic neuronal activity, to peripheral (plasma) chromogranin A, and to disease states such as hypertension, renal failure and Parkinsonism. Authentic, physically stable chromogranin A immunoreactivity was found in cerebrospinal fluid (at 37-146 ng/ml; mean, 87.0 +/- 6.0 ng/ml in healthy subjects), and several lines of evidence (including 3.39 +/- 0 .27-fold higher chromogranin A in cerebrospinal fluid than in plasma) indicated that it originated from a local central nervous system sourc e, rather than the periphery. Cerebrospinal fluid chromogranin A value s were not influenced by administration of effective antihypertensive doses of clonidine or propranolol, and were not related to the cerebro spinal fluid concentrations of norepinephrine, methoxyhydroxyphenylgly col, or dopamine-beta-hydroxylase; thus, cerebrospinal fluid chromogra nin A was not closely linked to biochemical or pharmacologic indices o f central noradrenergic neuronal activity. Cerebrospinal fluid chromog ranin A was not changed (P > 0. 1) in essential hypertension (84.2 +/- 14.0 ng/ml) or renal failure (72.2 +/- 13.4 ng/ml), despite a marked (7.1-fold; P < 0.001) increase in plasma chromogranin A in renal failu re, and a modest (1.5-fold; P = 0.004) increase in plasma chromogranin A in essential hypertension. In Parkinson's disease, a diminution (2. 8-fold; P < 0.001) of cerebrospinal fluid chromogranin A may be of dia gnostic value.